News | Stent Grafts | July 17, 2017

Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft

New Active Control delivery system provides controlled and predictable placement of stent graft for thoracic endovascular aortic repair

Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft

July 17, 2017 — W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft with Active Control System after receiving CE Mark last month. The first implant was performed by Prof. Dr. med. Giovanni Torsello and Dr. med. Martin Austermann at St. Franziskus Hospital, Munster, Germany.

The thoracic endovascular aortic repair (TEVAR) device is the first to feature a new delivery system that provides the physician with controlled, staged deployment, according to the company. The system optimizes accuracy, angulation and apposition to treat etiologies of the descending thoracic aorta including aneurysms, transections, and acute and chronic Type B dissections. The new device will be formally launched in European regions later this year.

The Gore Active Control System enhances the conformability of the stent graft, facilitating the optimized wall apposition of the Conformable Gore TAG Device even in complex anatomies, such as acute aortic angles. The novel staged deployment feature enables the physician to refine positioning and angulate the stent graft within the body to achieve optimal placement prior to full-diameter expansion. The angulation control capability gives physicians the option to angulate the device to achieve orthogonal placement to the aortic blood flow lumen and maximize conformability and seal. These features enable physicians to more confidently perform endovascular treatment even in anatomies where tortuous vessels might historically have suggested open surgery.

“The enhanced control capabilities this new delivery system allows could reduce many common complications that can occur if the stent graft is not placed correctly during the TEVAR procedure,” commented Torsello. “Secondary interventions can be traumatic for patients and costly to the provider. The innovative staged deployment feature of the Gore Active Control System provides a level of precision that has never existed in TEVAR. This level of control in combination with the long-term benefits of the stent graft is a significant advancement for the field.”

The new product offering features the same stent graft as the Conformable Gore TAG Device, whose outcomes have been established through its long-term freedom from reintervention (89 percent) and low serious endoleak (6 percent) and migration (0 percent) rates through five years, according to the TAG 08-03 clinical trial for treatment of aneurysms of the descending aorta. The device is a combination of proprietary ePTFE graft material and a fully supported, nested, nitinol stent.

For more information: www.gore.com

Related Content

FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall
News | Endovascular Aortic Repair | October 08, 2018
Endologix Inc. received notice that the U.S. Food and Drug Administration (FDA) has classified a voluntary recall...
The Gore TAG stent graft used in TEVAR aortic repair procedures for aneurysms.

The Gore TAG stent graft used for endovascular aortic aneurysm repair procedures.

Feature | Endovascular Aortic Repair | February 05, 2018 | Andrei Churyla, M.D., S. Chris Malaisrie, M.D.
Here are several considerations for physicians when choosing...
Endologix Receives IDE Approval for EVAS2 Confirmatory Clinical Study
News | Endovascular Aortic Repair | October 19, 2017
Endologix Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair | May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...
abdominal aortic aneurysm, AAA, gender differences, women vs. men, endovascular repair, Journal of Vascular Surgery study
News | Endovascular Aortic Repair | April 05, 2017
Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms...
Beaumont Hospital, Michigan, endovascular aortic repair, EVAR, conscious sedation
News | Endovascular Aortic Repair | July 08, 2016
Kirk Schoenherr, 56, of Clinton Township, Mich., recently became just the second patient at Beaumont Hospital, Royal...
Aptus Endosystems, Medtronic, acquisition, Heli-FX, Thoracic EndoAnchor, EVAR

Heli-FX image courtesy of Aptus Endosystems

News | Endovascular Aortic Repair | July 02, 2015
Medtronic plc announced it has acquired the assets of Aptus Endosystems Inc., a privately held medical device company...
Overlay Init